About Zachariah Serber
Zachariah Serber is a chief technology officer at Arkea Bio.
Zachariah Serber reports to the SEC as a director or officer of 1 public company: Zymergen (ZY).
Zachariah Serber first appears on SEC filings in 2021.
Experience
This experience comes from Zachariah Serber's profile and from SEC filings. For roles taken from filings, the years are when the filings name Zachariah Serber in the role, so the role may have started earlier or lasted longer.
AR
ArkeaBio™ Current
Chief Technology Officer
2022 – Present
Arkea Bio Corp.
Chief Technology Officer
2023 – 2026 · Charlestown, MA
Develops a vaccine to reduce methane emissions from cattle for livestock producers.
EV
Evozyne
Consultant
2022 – 2025
ZI
Zymergen Inc.
Chief Science Officer, Founder, Board Member
2013 – 2022 · Public company (ZY)
AI
Amyris Inc
Director, Biology
2007 – 2013
SS
Stanford University Medical School
Research Fellow
2003 – 2007
CS
Collegiate School
Physics teacher
1997 – 1998
Key Colleagues at Startups
The people Zachariah Serber works with at each company, as listed on that company's latest Form D.
Arkea Bio Corp. · Form D, Oct 9, 2026
